Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

DexCom, Inc. (DXCM) Return on invested capital

DexCom, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 37.1%, up 8.5 percentage points from fiscal 2025 (28.7%). Over the past ten years it has ranged from −40.4% (fiscal 2018) to 49.3% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −10.3% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 28.7% (20.67)
FY2024 49.3% 28.33
FY2023 21.0% 6.14
FY2022 14.9% 2.21
FY2021 12.7% (10.66)
FY2020 23.3% 2.28
FY2019 21.0% 61.46
FY2018 −40.4% (27.04)
FY2017 −13.4% 10.65
FY2016 −24.0% 8.91

Against its own ten years

Low −40.4% High 49.3%
Ten-year median 14.9%
Current reading's percentile 91

Return on invested capital against peers

Company Return on invested capital
DXCM DexCom, Inc. 37.1%
PEN Penumbra, Inc. compare 13.1%
EW Edwards Lifesciences Corporation compare 12.8%
GEHC GE HealthCare Technologies Inc. compare 8.37%
STE STERIS plc compare 8.27%
BSX Boston Scientific Corporation compare 6.96%
PHG Koninklijke Philips N.V. compare 6.69%
ZBH Zimmer Biomet Holdings, Inc. compare 3.82%
SNN Smith & Nephew SNATS, Inc. compare 0.00%
Medical Devices industry median −10.3%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on DXCM